Report on the International Colloquium on cardio-oncology (Rome, 12-14 March 2014)

Michael Ewer, Luca Gianni, Fabrizio Pane, Maria Teresa Sandri, Rudolf K. Steiner, Leszek Wojnowski, Edward T. Yeh, Joseph R. Carver, Steven E. Lipshultz, Giorgio Minotti, Gregory T. Armstrong, Daniela Cardinale, Steven D. Colan, Sarah C. Darby, Thomas L. Force, Leontien C M Kremer, Daniel J. Lenihan, Stephen E. Sallan, Douglas B. Sawyer, Thomas M. SuterSandra M. Swain, Flora E. Van Leeuwen

Research output: Contribution to journalArticlepeer-review


Cardio-oncology is a relatively new discipline that focuses on the cardiovascular sequelae of anti-tumour drugs. As any other young adolescent discipline, cardio-oncology struggles to define its scientific boundaries and to identify best standards of care for cancer patients or survivors at risk of cardiovascular events. The International Colloquium on Cardio-Oncology was held in Rome, Italy, 12-14 March 2014, with the aim of illuminating controversial issues and unmet needs in modern cardio-oncology. This colloquium embraced contributions from different kind of disciplines (oncology and cardiology but also paediatrics, geriatrics, genetics, and translational research); in fact, cardio-oncology goes way beyond the merging of cardiology with oncology. Moreover, the colloquium programme did not review cardiovascular toxicity from one drug or the other, rather it looked at patients as we see them in their fight against cancer and eventually returning to everyday life. This represents the melting pot in which anti-cancer therapies, genetic backgrounds, and risk factors conspire in producing cardiovascular sequelae, and this calls for screening programmes and well-designed platforms of collaboration between one key professional figure and another. The International Colloquium on Cardio-Oncology was promoted by the Menarini International Foundation and co-chaired by Giorgio Minotti (Rome), Joseph R Carver (Philadelphia, Pennsylvania, United States), and Steven E Lipshultz (Detroit, Michigan, United States). The programme was split into five sessions of broad investigational and clinical relevance (what is cardiotoxicity?, cardiotoxicity in children, adolescents, and young adults, cardiotoxicity in adults, cardiotoxicity in special populations, and the future of cardio-oncology). Here, the colloquium chairs and all the session chairs briefly summarised what was said at the colloquium. Topics and controversies were reported on behalf of all members of the working group of the International Colloquium on Cardio-Oncology.

Original languageEnglish
Article number433
Issue number1
Publication statusPublished - May 29 2014


  • Antitumor therapies
  • Cardio-oncology
  • Cardiovascular sequelae
  • Patients
  • Survivors

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Report on the International Colloquium on cardio-oncology (Rome, 12-14 March 2014)'. Together they form a unique fingerprint.

Cite this